Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Professor Stephen Maher

Professor In (Surgery)
      
Profile Photo

Professor Stephen Maher

Professor In (Surgery)

 maherst@tcd.ie

 


Prof Maher graduated from RCSI with a PhD in Oncology. In 2004 he secured a fellowship from the National Cancer Institute in Maryland, and spent 3 years working on novel immunotherapeutics for cancer. In 2007 he returned to Ireland and the Department of Surgery at Trinity College Dublin, St. James's Hospital, as a research fellow. In 2010 he secured an Irish Cancer Society Fellowship and established his own research group, focusing on cellular and molecular mechanisms underpinning responses to chemoradiation in patients with GI cancers. In 2012 he joined the University of Hull and Hull York Medical School as a Senior Lecturer/Associate Professor, where he led the Cancer Biology and Therapeutics lab. During his time in the UK he gained substantial teaching experience and qualifications, and developed and directed new UG and PG teaching programmes in Oncology. He is a fellow of the UK Higher Education Academy. In 2016 Stephen returned to TCD as the Ussher Assistant Professor in Translational Oncology, Radiation Therapy and Chemotherapy. Stephen delivers oncology teaching and training at both the UG and PG level at TCD and is on the education advisory board for the Trinity St. James Cancer Institute. He leads national and international collaborative programmes in translational oesophageal and pancreatic cancer research, focusing on IPMN biology and patient risk stratification, radiobiology, and radiotherapy and chemotherapy resistance. He established and runs unique hypoxia and radiotherapy research cores at the Trinity Translational Medicine Institute. He has secured in excess of €5.5m in competitive research funding, is well published in the field of microRNAs, GI cancer and therapeutics research, and has won numerous national and international awards for his work. Prof Maher has successfully supervised 9 PhD students and has mentored several postdoctoral researchers who have gone on to develop independent cancer research careers. In 2020 he was promoted to Associate Professor and then to Professor in 2024. He is currently the Director of Postgraduate Studies for the School of Medicine. Stephen was elected to fellow of TCD in 2024.
  Apoptosis   Apoptosis, molecular control   Autoimmune and hypersensitivity diseases   Autoimmunity   Bioinformatics   Breast cancer   Cancer genetics and cell biology including metastasis   Cell cycle control   Cell Death   Cellular, molecular and developmental immunology   Chronic Disease   Chronic inflamation   Coagulation biochemistry and disorders   Cytokines, Nitric Oxide   Cytoskelton, cell division   DNA transcription and translation   Gene targeting in breast cancer   Gene therapy   Gene transcription in human cancer   General surgery, upper GI, colorectal and breast   Genetic/Molecular epidemiology   Genomics   Haemotology   Human genetics   Immune system   Immunoassays   Immunochemistry and immunogenetics   Immunological response to surgical trauma   Immunotherapies   Immunotherapies for Cancer   Inflammation and coagulation syndromes   Inflammatory bowel disease   Innate immunology   Intra and intercellular signalling   Leukemias and lymphomas   Leukocyte Biology   Mammilian and human genetics and genomics   Membrane and protein trafficking   Mucosal immunology   Oesophageal cancer   Oesophageal, gastric, intestinal and pancreatic diseases   Oncogenes, apoptosis and tumour development   Protein processing, stability and regulation   Protein sequence, function and expression   Quantitative and molecular genetics   Radiotherapy   Radiotherapy, Biological response modifiers and chemoprevention   Regulatory methods of gene expression   RNA processing, stability and degradation   Stem Cell biology and hematopoiesis   Therapeutic and Clinical oncology   Therapeutic radiography   Tumour immunology and immunotherapy   Vascular Biology, Thrombosis
Project Title
 The role of microRNA and random mitochondrial DNA mutations in a novel clinically-relevant isogenic model of radioresistance in oesophageal adenocarcinoma
From
2011
To
2013
Summary
Funding Agency
Health Research Board
Programme
Health Research Award
Person Months
24
Project Title
 Tissue and Serum microRNA signatures for predicting response to chemoradiotherapy for oesophageal adenocarcinoma
From
2010
To
2013
Summary
Funding Agency
Irish Cancer Society
Programme
Research Fellowship
Project Type
Research Fellowship
Person Months
36
Project Title
 The role of the chemokine CCL28 (MEC) in oesophageal adenocarcinoma progression: interaction between the immune system and the tumour
From
2010
To
2013
Summary
Funding Agency
Irish Cancer Society
Programme
Research Scholarship
Project Type
Cancer biology, immunology
Person Months
36
Project Title
 The role of a cancer stem-like cells in an isogenic model of radioresistance in oesphageal adenocarcinoma
From
2012
To
2016
Summary
Funding Agency
Health Research Board
Programme
Health Research Awards
Project Type
patient-orientated research
Project Title
 The role of miR-330 and miR-187 in regulating sensitivity to chemoradiation in oeosphageal adenocarcinoma
From
2013
To
2015
Summary
Funding Agency
Cancer and Polio Research Fund UK
Project Type
Basic research
Person Months
48

Page 1 of 4
Details Date
Editorial Board, Frontiers in Oncology - Associate Editor - Molecular and Cellular Oncology 2017
Editorial Board, Frontiers in Cell and Developmental Biology - Associate Editor 2018
Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent
German Medium Basic Medium
Irish Medium Medium Medium
Details Date From Date To
Irish Association of Radiation Research (IRRS) 2016 Present
Association of Radiation Research (UK) 2015 Present
Mesothelioma Research Network (MRN) 2014 present
Biochemical Society UK 2013 Present
Clinical Trials Ireland (formerly ICORG) 2009 present
British Association of Cancer Research (BACR) 2013 Present
European Association of Cancer Research (EACR) 2009 Present
Irish Association of Cancer Research (IACR) 2008 Present
American Association of Cancer Research (AACR): Associate Member 2006 Present
British Lung Foundation 2013 2016
International Society for Interferon and Cytokine Research (ISICR) 2004 2009
Laura Kane, Gregory S. Mellotte, Eimear Mylod, Paul Dowling, Simone Marcone, Caitríona Scaife, Elaine Kenny, Michael Henry, Paula Meleady, Paul F. Ridgway, F MacCarthy, Kevin C. Conlon, Barbara M. Ryan, Stephen G. Maher, Multi-omic biomarker panel in pancreatic cyst fluid and serum predicts patients at a high risk of pancreatic cancer development, Scientific Reports, 15, (1), 2025, Journal Article, PUBLISHED  DOI
Kate Connor, Kieron White, James Clerkin, Kieron J. Sweeney, Liam Shiels, Thomas Van Brussel, Ingrid Arijs, Diether Lambrechts, Gautam Shankar, Frederik De Smet, Stephen G. Maher, Laure Marignol, Patrick Dicker, Jochen H.M. Prehn, David O"Brien, Annette T. Byrne, Abstract 1441: Establishing a novel clinically relevant disease model of glioblastoma, Cancer Research, 84, (6_Supplement), 2024, p1441 - 1441, p1441-1441 , Journal Article, PUBLISHED  DOI
Simone Marcone, Jolanda Spadavecchia, Memona Khan, Gabriele Vella, Fiona O"Connell, Marzia Pendino, Meghana Menon, Claire Donohoe, Narayanasamy Ravi, John V. Reynolds, Stephen G. Maher, Niamh Lynam"Lennon, Breandán N. Kennedy, Adriele Prina"Mello, Jacintha O"Sullivan, Targeting Radiation Resistance in Oesophageal Adenocarcinoma with Pyrazinib-Functionalised Gold Nanoparticles, Cancers, 16, (23), 2024, p4007 - 4007, p4007-4007 , Journal Article, PUBLISHED  DOI
Maitiú Ó Murchú, Xuehua Lin, Melissa Anne Tutty, Christina Cahill, Ian S. Miller, Lasse Jensen, Adriele Prina"Mello, Niamh Lynam"Lennon, Stephen G. Maher, Helena Kelly, Jacintha O"Sullivan, Enhancing cancer radiotherapy efficacy using NanOx, a novel oxygenating perfluorocarbon nanoemulsion that reverses tumour hypoxia., Cancer Letters, 2024, p217406 - 217406, p217406-217406 , Journal Article, PUBLISHED  DOI
Donlon, N.E. and Davern, M. and Sheppard, A. and O'Connell, F. and Moran, B. and Nugent, T.S. and Heeran, A. and Phelan, J.J. and Bhardwaj, A. and Butler, C. and Ravi, N. and Donohoe, C.L. and Lynam-Lennon, N. and Maher, S. and Reynolds, J.V. and Lysaght, J., Potential of damage associated molecular patterns in synergising radiation and the immune response in oesophageal cancer, World Journal of Gastrointestinal Oncology, 15, (8), 2023, p1349-1365 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Davern, M. and Gaughan, C. and O†Connell, F. and Moran, B. and Mylod, E. and Sheppard, A.D. and Ramjit, S. and Yun-Tong Kung, J. and Phelan, J.J. and Davey, M.G. and Ryan, E.J. and Butler, C. and Quinn, L. and Howard, C. and Tone, E. and Phoenix, E. and Butt, W.T. and Lynam-Lennon, N. and Maher, S.G. and Ravi, N. and Donohoe, C.L. and Reynolds, J.V. and Lysaght, J. and Donlon, N.E., PD-1 blockade attenuates surgery-mediated immunosuppression and boosts Th1 immunity perioperatively in oesophagogastric junctional adenocarcinoma, Frontiers in Immunology, 14, (1150754), 2023, Notes: [cited By 1], Journal Article, PUBLISHED  DOI
Cannon, A. and Maher, S.G. and Lynam-Lennon, N., Generation and Characterization of an Isogenic Cell Line Model of Radioresistant Esophageal Adenocarcinoma, Methods in Molecular Biology, 2645, 2023, p139-152 , Notes: [cited By 0], Journal Article, PUBLISHED  DOI
Kate Connor, Kieron White, James Clerkin, Liam Shiels, Kieron J. Sweeney, Thomas Van Brussel, Ingrid Arijs, Diether Lambrechts, Gautam Shankar, Frederik De Smet, Dieter Zopf, Stephen G. Maher, Laure Marignol, Patrick Dicker, Jochen H.M. Prehn, David O"Brien, Annette T. Byrne, EXTH-64. ESTABLISHING A CLINICALLY RELEVANT MOUSE MODEL OF MESENCHYMAL GLIOBLASTOMA FOR STUDYING TME TARGETING TREATMENTS, Neuro-Oncology, 25, (Supplement_5), 2023, pv238 - v239, pv238-v239 , Journal Article, PUBLISHED  DOI
Kane LE, Mellotte GS, Mylod E, O'Brien RM, O'Connell F, Buckley CE, Arlow J, Nguyen K, Mockler D, Meade AD, Ryan BM, Maher SG, Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: A systematic review and meta-analysis, Gastroenterology, 2022, Journal Article, SUBMITTED
McGrath J, Kane LE, Lowery ME, Maher SG, The influence of microRNA-31 on oxidative stress and radiosensitivity in pancreatic ductal adenocarcinoma, International Journal of Molecular Sciences, 2022, Journal Article, SUBMITTED
  

Page 1 of 9
Maher SG, Point-of-care testing versus lab-based testing - striking a balance, Konstanz, Germany, 2021, BioLago, Invited Talk, PRESENTED
Kane LE, Mellotte GS, Mylod E, O'Brien RM, O'Connell F, Buckley CE, Arlow J, Nguyen K, Mockler D, Meade AD, Ryan BM, Maher SG, Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: A systematic review and meta-analysis, Cancer Research, 2021, 2021, pp6 - 7, Poster, PUBLISHED
Maher SG, Modelling radioresistance in vitro, The role of radiotherapy in a stratified approach to the treatment of oesophageal cancer, London - Cambridge University, 10 June 2019, 2019, Invited Talk, PRESENTED
Stephen Maher, Cancer - The Patient Journey, 60th London International Youth Science Forum, London, UK, 2018, 2018, Oral Presentation, PRESENTED
Stephen Maher, MicroRNAs as modulators of therapeutic sensitivity, MicroRNA Europe Annual Conference, Cambridge, UK, 2016, 2016, Oral Presentation, PRESENTED
Cawthorne C, Maher SG, Ahmed N, Beavis AW, Improving the application of PET to radiotherapy via preclinical research: status and potential, RAD Magazine, 42, (492), 2016, p29 - 30, Review Article, PUBLISHED
Maher SG, Reynolds JV, Oesophageal cancer: The potential of modern molecular tools in treatment, Cancer Professional, 6, 2012, p21 - 25, Review Article, PUBLISHED

  


Award Date
1st prize - best basic science paper - iCHAMS international conference (supervisor) 2022
1st prize - best scientific paper - Irish Society of Gastroenterology (supervisor) 2021
Patrick G. Johnston Award - Irish Association of Cancer Research (supervisor) 2021
Irish Lab Awards - Research Lab of the Year 2019
1st prize - best poster - TSJCI 11th International Cancer Conference (supervisor) 2019
Association of Radiation Research (ARR) SIT bursary (supervisor) 2017
iMig Young Investigator Award (Supervisor) 2016
Researcher of the Year, Hull York Medical School (Supervisor) 2016
NCRI Hamilton-Fairley Young Investigator Awards (double-shortlisting) (Supervisor) 2015
1st Prize, Best Research Paper, 12th Annual International Medical Postgraduate Conference, Charles University in Prague (Supervisor) 2015
1st Prize, Best Poster, UK Radiation Oncology (UKRO) Annual Meeting (Supervisor) 2015
1st Prize, Best Research Paper, 11th Annual International Medical Postgraduate Conference, Charles University in Prague (Supervisor) 2014
Biochemical Society Summer Studentship (Supervisor) 2013
Researcher of the Year, Irish Cancer Society 2013
Patey Prize, SARS Annual Meeting 2011
Fellowship, Irish Cancer Society 2010
Roche Researcher of the Year, TCD (Supervisor) 2010
Poster Prize, 7th International Cancer Conference (Dublin) 2009
1st Prize, TCD Molecular Medicine Entrepreneurship Course 2009
Travel Award, St. James's Hospital Dublin 2009
Donald Weir Medal for Research, Trinity College Dublin 2008
Oncology Scholars Travel Award, Irish Cancer Society 2008
Fellowship, National Cancer Institute (USA) 2004
Irish Representative at 39th LIYSF 1997
Stephen has always been interested in cancer and its treatment. Having completed a PhD that examined T cell biology and interleukin-2 therapy for melanoma and renal cell carcinoma, he moved the the National Cancer Institute in the USA to pursue postdoctoral studies in the anti-tumour potential of a newly discovered cytokine, interferon-lambda (IL-29). Over the past 15 years his research interests have largely focused on understanding and predicting tumour response and resistance to more conventional, broadly applicable, cancer treatments, specifically chemotherapy and radiotherapy. Stephen's group examines the influence of the microRNA compartment, DNA damage response and, more recently hypoxia, on regulating cellular sensitivity to chemotherapy and radiotherapy in oesophageal and mesothelial tumours. His team is internationally recognised as leaders in translational radiotherapy research. More recently he initiated and leads an award-winning pancreatic cancer research programme. Being a member of the department of surgery at TTMI, based at St. James's Hospital in Dublin, his work is highly patient centric.